Latest News
Instem Awarded EMA Research Grant
Instem Secures Portion of €2.5m Grant as Member of Research Consortium Investigating the Mutagenicity of N-nitrosamines
PHILADELPHIA, PA – (BUSINESS WIRE) – May 10, 2022 - Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has been awarded a European Medicines Agency (EMA) grant as part of an EMA-funded research project to better understand the mutagenicity of N-nitrosamines.
Instem Expands In Silico Toxicology Service To Meet Growing Demand
November 22, 2021 - Newly Added Services to Support Latest Regulatory Guidance and Growing Demand for Alternative Testing Methods
Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently
September 1, 2021 - Acquisition of PDS Life Sciences Consolidates Non-Clinical Market; Further Extends Instem’s Leadership in Study Management and Regulatory SEND Submission Support
Instem to Release Next Edition of its Leading Computational Toxicology Software Suite
July 29, 2021 - Powerful New In Silico Models and First-to-Market Software Capabilities to Deliver Further Efficiencies and Increased Regulatory Compliance
Instem Acquires Market Leader d-wise to Further Accelerate Life Science Development
March 22, 2021 - Instem’s Acquisition of Leading Clinical Trial Technology and Consulting Provider d-wise Represents Substantial Advancement of its Mission
Events
ICEM 2022 Annual Meeting
August 27 - September 1, 2022
Ottawa, Canada
Presentation:
'ICH M7 expert review procedures and assessment of specific chemical classes', Kevin Cross
RAPS US Convergence 2022
September, 11 - 13, 2022
Phoenix Convention Center, Phoenix, Arizona, Booth #823
SPS Annual Meeting 2022
September, 11 - 14, 2022
Palais des congrès de Montréal, Montreal, Booth #803